Omnipod 5 Launches in Middle East, Transforming Diabetes Care

David Wilson · 2026-02-10

Big news for diabetes care in the Middle East just landed. Insulet Corporation, the folks behind the tubeless Omnipod insulin pump, announced their Omnipod 5 Automated Insulin Delivery System is now available in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates. And they didn't stop there—they're also rolling out a brand-new data platform called Omnipod Discover. It's a major step for a region with significant need for advanced diabetes management tools. Pat Crannell, Insulet's Senior VP and International General Manager, put it simply. "We're proud to bring Omnipod 5 to a region where the unmet need is great," he said. "These launches build on our momentum as we continue to transform lives worldwide." He highlighted that the launch of Omnipod Discover makes the move even more impactful, aiming to create a world where diabetes demands less from people every single day. ### How the Omnipod 5 System Works So, what's the big deal with Omnipod 5? Think of it as a smart, wearable assistant for managing type 1 diabetes. It's the first tubeless automated insulin delivery (AID) system that talks directly to a continuous glucose sensor. Here's the kicker—it automatically adjusts insulin delivery every five minutes. That means it's constantly working in the background, proactively correcting for high blood sugar and helping protect against lows, 24/7. This isn't just about convenience, though that's a huge part of it. The system has demonstrated strong results in improving "time in range" and lowering HbA1c levels. For anyone tired of multiple daily injections, this wearable, waterproof device could be a game-changer. It's indicated for individuals aged two years and older and is compatible with popular sensors like the Abbott FreeStyle Libre 2 Plus and the Dexcom G7 in these new markets. ### Simplifying Data with Omnipod Discover Managing diabetes generates a ton of data. It can feel overwhelming. That's where the new Omnipod Discover platform comes in. It's a web-based analytics tool designed to take all that complex glucose and insulin delivery information and turn it into clear, actionable insights. The goal is to lessen the burden on both users and their healthcare providers. Instead of staring at spreadsheets of numbers, Omnipod Discover shows trends and offers recommendations. It visually displays how the Omnipod 5 algorithm is working, helping everyone involved understand what's happening and make confident decisions about care. It's about empowerment through clarity. ### A Local Perspective on the Launch The local medical community is welcoming this innovation. Dr. Mohammed Almehthel, a diabetes technology expert in Saudi Arabia, noted the region's eagerness for solutions like Omnipod 5. "As our diabetes care standards evolve to embrace advanced technologies," he said, "this introduction represents an important step forward that will transform daily life for many individuals and their families." And the excitement isn't just professional—it's personal. Khalid Al Shethri from Riyadh shared his family's story, expressing happiness that his nine-year-old daughter Yasmeen is beginning her journey with the Omnipod 5 system. ### What's Next for Global Expansion? Insulet is starting Omnipod Discover in these Middle Eastern markets first, with plans to expand it to other countries where Omnipod 5 is available. Speaking of expansion, with this launch, Omnipod 5 is now in 19 countries globally. The company isn't slowing down. They plan to enter Spain as a new market in 2026, followed by Greece and Croatia in the first half of 2027. It's a clear signal that the future of diabetes management is becoming more automated, more connected, and frankly, a bit easier to live with. For professionals in the field, keeping an eye on how these technologies perform and integrate into care standards in different regions will be key. The data from platforms like Omnipod Discover will likely shape best practices for years to come.